Correlation Engine 2.0
Clear Search sequence regions

  • cells (1)
  • CHGA (5)
  • CHR (8)
  • chromofungin (2)
  • colitis (6)
  • cytokines (2)
  • dextran (2)
  • macrophage (6)
  • NF- κB (2)
  • peptides (1)
  • research (1)
  • sodium (2)
  • TLR (1)
  • toll- like receptors 4 (1)
  • vitro (1)
  • Sizes of these terms reflect their relevance to your search.

    Chromogranin-A (CHGA) is a prohormone secreted by neuroendocrine cells and is a precursor of several bioactive peptides, which are implicated in different and distinctive biological and immune functions. Chromofungin (CHR: CHGA47-66) is a short peptide with antimicrobial effects and encodes from CHGA exon-IV. Inflammatory bowel disease (IBD) is characterized by alterations in the activation of pro-inflammatory pathways, pro-inflammatory macrophages (M1), and nuclear transcription factor kappa B (NF-κB) signaling leading to the perpetuation of the inflammatory process. Here, we investigated the activity of CHR (CHGA Exon-IV) in persons with active ulcerative colitis (UC) and the underlying mechanisms in dextran sulfate sodium (DSS)-colitis in regard to macrophages activation and migration. Tissue mRNA expression of CHR (CHGA Exon-IV) was down regulated in active UC compared to healthy individuals and negatively correlated with pro-inflammatory macrophages (M1) cytokines, toll-like receptors (TLR)-4, and pNF-κB activity. In DSS colitis, CHR (CHGA Exon-IV) expression was reduced, and exogenous CHR treatment decreased the severity of colitis associated with a reduction of M1 macrophages markers and pNF-κB. In vitro, CHR treatment reduced macrophages migration, decreased pro-inflammatory cytokines production and pNF-κB. Targeting CHR may represent a promising new direction in research to define new therapeutic targets and biomarkers associated with IBD. Copyright © 2017 Elsevier Inc. All rights reserved.


    Nour Eissa, Hayam Hussein, Laëtitia Kermarrec, Omar Elgazzar, Marie-Helene Metz-Boutigue, Charles N Bernstein, Jean-Eric Ghia. Chromofungin (CHR: CHGA47-66) is downregulated in persons with active ulcerative colitis and suppresses pro-inflammatory macrophage function through the inhibition of NF-κB signaling. Biochemical pharmacology. 2017 Dec 01;145:102-113

    PMID: 28827109

    View Full Text